Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19345445 | METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY | September 2025 | January 2026 | Allow | 3 | 1 | 0 | Yes | No |
| 19069812 | METHODS TO GENERATE POLYMER SCAFFOLDS HAVING A GRADIENT OF CROSSLINKING DENSITY | March 2025 | February 2026 | Allow | 11 | 1 | 1 | Yes | No |
| 18846159 | IN CHEMICO TEST FOR TOXICITY | September 2024 | January 2026 | Allow | 16 | 2 | 1 | No | No |
| 18630584 | METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY | April 2024 | August 2024 | Allow | 5 | 1 | 0 | Yes | No |
| 18595392 | LARGE-SCALE PRODUCTION OF MYCELIUM-BASED TEXTILES AT MUSHROOM FARM FACILITIES | March 2024 | May 2025 | Allow | 14 | 1 | 0 | Yes | No |
| 18440328 | Stable Inoculant Compositions and Methods for Producing Same | February 2024 | December 2025 | Allow | 22 | 1 | 0 | Yes | No |
| 18419836 | ENZYME-ASSISTED ATRP PROCEDURES | January 2024 | April 2025 | Abandon | 14 | 1 | 0 | No | No |
| 18415272 | MECHANISM BASED QUALITY CONTROL FOR BOTANICAL MEDICINE | January 2024 | September 2025 | Abandon | 20 | 1 | 0 | No | No |
| 18524494 | BACTERIAL CULTURES AND METHODS FOR PRODUCTION OF ALGINATE | November 2023 | March 2025 | Allow | 15 | 1 | 1 | Yes | No |
| 18523358 | METHODS OF PROCESSING LIGNOCELLULOSIC BIOMASS USING SINGLE-STAGE AUTOHYDROLYSIS AND ENZYMATIC HYDROLYSIS WITH C5 BYPASS AND POST-HYDROLYSIS | November 2023 | May 2025 | Allow | 18 | 1 | 0 | No | No |
| 18520265 | TISSUE PRESERVATION SYSTEM | November 2023 | December 2024 | Abandon | 13 | 1 | 0 | No | No |
| 18558863 | A Bioreactor and Process for Forming Polyhydroxybutyrate Directly from Depolymerized Polyhydroxybutyrate | November 2023 | June 2025 | Allow | 19 | 1 | 1 | Yes | No |
| 18382410 | SYSTEM FOR GROWING FUNGAL MATERIALS | October 2023 | April 2025 | Abandon | 18 | 1 | 1 | No | No |
| 18382446 | Nutritional Formulas Comprising Medium Chain Fatty Acids or Esters Thereof and Methods Related Thereto | October 2023 | January 2026 | Allow | 27 | 1 | 0 | No | No |
| 18371651 | COMPOSITIONS AND METHOD OF USE FOR H5 COMPETENT BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS | September 2023 | June 2025 | Allow | 21 | 1 | 1 | Yes | No |
| 18455533 | CELLULOSE NANOFIBRILLAR BIOINK FOR 3D BIOPRINTING FOR CELL CULTURING, TISSUE ENGINEERING AND REGENERATIVE MEDICINE APPLICATIONS | August 2023 | February 2025 | Abandon | 18 | 0 | 1 | No | No |
| 18220535 | METHODS TO GENERATE POLYMER SCAFFOLDS HAVING A GRADIENT OF CROSSLINKING DENSITY | July 2023 | May 2025 | Abandon | 22 | 2 | 1 | No | No |
| 18219445 | Method for Treating Recycled Aggregates via Microbial-Induced Calcite Precipitation | July 2023 | January 2026 | Allow | 31 | 1 | 0 | Yes | No |
| 18341692 | METHODS OF PREPARING T CELLS FOR T CELL THERAPY | June 2023 | February 2025 | Abandon | 20 | 2 | 0 | Yes | No |
| 18254531 | LIMOSILACTOBACILLUS REUTERI STRAIN WITH HIGH RIBOFLAVIN PRODUCTION AND USES THEREOF | May 2023 | March 2026 | Allow | 33 | 2 | 0 | No | No |
| 18319085 | METHOD OF PRODUCING THIN ENZYME-BASED SENSING LAYERS ON PLANAR SENSORS | May 2023 | December 2023 | Allow | 7 | 0 | 0 | Yes | No |
| 18298783 | ENZYMATIC MODIFICATION OF OIL | April 2023 | February 2026 | Allow | 34 | 2 | 0 | No | No |
| 18177070 | SIALYLTRANSFERASES FOR IN VIVO SYNTHESIS OF 3'SL | March 2023 | August 2024 | Allow | 18 | 1 | 1 | No | No |
| 18166412 | METHOD FOR STABILIZATION AND DELIVERY OF THERAPEUTIC MOLECULES | February 2023 | September 2024 | Allow | 19 | 3 | 0 | Yes | No |
| 18163862 | COMPOSITIONS FOR EXPOSING FILM-FORMING MICROBES AND METHODS FOR USE OF THE COMPOSITIONS | February 2023 | December 2025 | Abandon | 34 | 1 | 1 | No | No |
| 18162957 | CONTROLLED OUTGASSING OF HYPERBARICALLY LOADED MATERIALS FOR THE DELIVERY OF OXYGEN AND OTHER THERAPEUTIC GASES IN BIOMEDICAL APPLICATIONS | February 2023 | September 2024 | Allow | 19 | 1 | 0 | Yes | No |
| 18104578 | METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY | February 2023 | January 2024 | Allow | 11 | 0 | 0 | Yes | No |
| 18007432 | BACTERIOPHAGE, BACTERIAL WILT DISEASE CONTROL AGENT, AND BACTERIAL WILT DISEASE CONTROL METHOD | January 2023 | December 2025 | Allow | 35 | 1 | 0 | Yes | No |
| 18097755 | OPEN-TOP MICROFLUIDIC DEVICE WITH STRUCTURAL ANCHORS | January 2023 | July 2023 | Allow | 6 | 0 | 1 | Yes | No |
| 18012318 | SYNERGISTIC COMPOSITION OF PHAGES AND ITS FORMATION METHOD | December 2022 | February 2026 | Abandon | 38 | 0 | 1 | No | No |
| 18002357 | METHOD FOR CULTURING MICROORGANISMS FOR LIPID ACCUMULATION | December 2022 | December 2025 | Abandon | 36 | 1 | 1 | No | No |
| 18010792 | AUTOTRANSPORTER SYSTEM | December 2022 | February 2026 | Abandon | 38 | 0 | 1 | No | No |
| 18007727 | SERUM BIOMARKERS FOR PREDICTING AND PREVENTING HEMORRHAGIC STROKE | December 2022 | March 2026 | Abandon | 39 | 1 | 0 | No | No |
| 17993690 | SATELLITE CELLS AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME | November 2022 | February 2023 | Allow | 3 | 0 | 0 | Yes | No |
| 18058042 | MECHANISM BASED QUALITY CONTROL FOR BOTANICAL MEDICINE | November 2022 | October 2023 | Allow | 10 | 0 | 0 | Yes | No |
| 17923955 | RECOMBINANT BACTERIA FOR PRODUCTION OF INDOLE-3-ACETIC ACID (IAA) AND USES THEREOF | November 2022 | February 2026 | Abandon | 39 | 0 | 1 | No | No |
| 18051215 | SELF-ASSEMBLING MULTICELLULAR BODIES AND METHODS OF PRODUCING A THREE-DIMENSIONAL BIOLOGICAL STRUCTURE USING THE SAME | October 2022 | November 2025 | Abandon | 37 | 2 | 1 | No | Yes |
| 17967598 | TISSUE PRESERVATION SYSTEM | October 2022 | August 2023 | Allow | 10 | 1 | 0 | Yes | No |
| 17938509 | ENGINEERED BIFIDOBACTERIUM STRAINS COMPRISING A TRANSGENE | October 2022 | December 2025 | Abandon | 38 | 0 | 1 | No | No |
| 17938539 | ENGINEERED BACTERIAL STRAINS COMPRISING A TRANSGENE | October 2022 | December 2025 | Abandon | 38 | 0 | 1 | No | No |
| 17937553 | USE OF MICROBIAL COMMUNITIES FOR HUMAN AND ANIMAL HEALTH | October 2022 | January 2023 | Allow | 3 | 0 | 0 | Yes | No |
| 17937554 | USE OF MICROBIAL COMMUNITIES FOR HUMAN AND ANIMAL HEALTH | October 2022 | January 2023 | Allow | 3 | 0 | 0 | Yes | No |
| 17995367 | METHOD FOR PRODUCING SULFATED POLYSACCHARIDE AND METHOD FOR PRODUCING PAPS | October 2022 | November 2024 | Allow | 26 | 3 | 0 | Yes | No |
| 17915538 | BIOCATALYST AS A CORE COMPONENT OF AN ENZYME-CATALYZED REDOX SYSTEM FOR THE BIOCATALYTIC REDUCTION OF CYSTINE | September 2022 | January 2026 | Allow | 39 | 2 | 1 | No | No |
| 17914054 | METHODS FOR PRODUCING HEME PEROXIDASES | September 2022 | August 2025 | Allow | 35 | 1 | 1 | Yes | No |
| 17934119 | METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY | September 2022 | January 2023 | Allow | 3 | 0 | 0 | Yes | No |
| 17933484 | ANTIBIOTIC COMPOSITION AND METHOD OF MANUFACTURING THE SAME | September 2022 | December 2025 | Abandon | 38 | 4 | 1 | Yes | No |
| 17942952 | ENZYME-ASSISTED ATRP PROCEDURES | September 2022 | October 2023 | Allow | 13 | 1 | 0 | Yes | No |
| 17905700 | Production Of Vaccines Comprising Inactivated SARS-COV-2 Viral Particles | September 2022 | December 2025 | Allow | 60 | 1 | 0 | Yes | No |
| 17815539 | MICROORGANISMS SYNTHESIZING ANTI-INFLAMMATORY MOLECULES | July 2022 | October 2025 | Abandon | 39 | 1 | 1 | No | No |
| 17794217 | ANTITUMOR VIRUS | July 2022 | November 2025 | Allow | 40 | 1 | 1 | Yes | No |
| 17864154 | PROCESS FOR TREATING WATERS, SOILS, SEDIMENTS AND/OR SLUDGES | July 2022 | March 2025 | Allow | 32 | 3 | 1 | Yes | No |
| 17792030 | BACTERIA ENGINEERED TO TREAT DISORDERS IN WHICH OXALATE IS DETRIMENTAL | July 2022 | October 2025 | Abandon | 39 | 0 | 1 | No | No |
| 17792052 | CENTRIFUGAL MICROFLUIDIC DEVICE WITH BLOCKING AND DETECTION CHAMBERS | July 2022 | November 2025 | Abandon | 40 | 0 | 1 | No | No |
| 17791835 | CONDITIONALLY REPLICATING M. BOVIS BCG | July 2022 | December 2025 | Abandon | 41 | 1 | 1 | No | No |
| 17758002 | PROCESS OF OBTAINING BETA-GLUCAN FROM BAKERS YEAST | June 2022 | September 2025 | Abandon | 38 | 1 | 0 | No | No |
| 17835601 | BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION AND/OR TIGHTENED GUT MUCOSAL BARRIER | June 2022 | October 2025 | Abandon | 40 | 0 | 1 | No | No |
| 17781960 | COMPOSITION FOR TREATING DIABETIC RETINOPATHY, COMPRISING RAAV CONTAINING SOLUBLE VEGFR-1 VARIANT CDNA | June 2022 | September 2025 | Abandon | 40 | 1 | 0 | No | No |
| 17778201 | METHOD FOR PRODUCING 3,5-DIHYDROXY-4-METHOXYBENZYL ALCOHOL FROM PLANKTON | May 2022 | February 2025 | Allow | 33 | 1 | 0 | No | No |
| 17737424 | METHOD FOR STABILIZATION AND DELIVERY OF THERAPEUTIC MOLECULES | May 2022 | November 2022 | Allow | 6 | 0 | 0 | Yes | No |
| 17733531 | METHODS FOR DETECTION, DETERMINATION, AND ACTIVITY MEASUREMENT OF PEROXIDASE BASED ON CHEMILUMINESCENCE | April 2022 | September 2023 | Allow | 16 | 1 | 0 | No | No |
| 17728480 | SYSTEM FOR GROWING FUNGAL MATERIALS | April 2022 | September 2023 | Allow | 17 | 1 | 0 | Yes | No |
| 17765548 | Methods for Isolating Single-Molecule Products | March 2022 | July 2024 | Abandon | 27 | 1 | 1 | No | No |
| 17763761 | PROCESSES AND SYSTEMS FOR BIOLOGICAL HYDROGEN PRODUCTION FROM ORGANIC WASTE USING YEAST | March 2022 | September 2024 | Allow | 30 | 1 | 0 | Yes | No |
| 17685014 | TREATING NEURODEGENERATIVE DISEASES WITH PROGRANULIN | March 2022 | September 2025 | Abandon | 43 | 1 | 0 | No | No |
| 17753324 | ACTIVITY BASED PROBES | February 2022 | March 2025 | Allow | 36 | 1 | 1 | Yes | No |
| 17637414 | PLASMIDS | February 2022 | September 2025 | Abandon | 43 | 0 | 1 | No | No |
| 17674913 | Oleaginous Yeast and its application | February 2022 | September 2024 | Allow | 31 | 1 | 0 | No | No |
| 17671262 | MICROBIAL COMPOSITIONS AND METHODS | February 2022 | January 2024 | Allow | 23 | 0 | 0 | Yes | No |
| 17671479 | ADIPOSE TISSUE-DERIVED STROMAL STEM CELLS FOR USE IN TREATING REFRACTORY COMPLEX PERIANAL FISTULAS IN CROHN'S DISEASE | February 2022 | September 2024 | Allow | 31 | 3 | 0 | Yes | No |
| 17634162 | Production of Fatty Acid Esters Using a Yeast Culture | February 2022 | October 2024 | Abandon | 32 | 0 | 1 | No | No |
| 17583067 | PapQuin-50 a Quinoa grain-based bacterial growth medium nitrogen source | January 2022 | November 2023 | Allow | 21 | 0 | 1 | Yes | No |
| 17629694 | ENZYME CAPABLE OF DEHYDROXYLATING HYDROXYL GROUP IN UROLITHIN COMPOUND | January 2022 | August 2025 | Allow | 43 | 1 | 1 | Yes | No |
| 17571555 | HEALTH FOOD FOR PROMOTION OF QUALITY OF SLEEPY AND METABOLISM | January 2022 | March 2024 | Abandon | 26 | 1 | 0 | No | No |
| 17621121 | OPTIMIZED BACTERIA ENGINEERED TO TREAT DISORDERS INVOLVING THE CATABOLISM OF LEUCINE, ISOLEUCINE, AND/OR VALINE | December 2021 | June 2025 | Abandon | 42 | 0 | 1 | No | No |
| 17556966 | COMPOSITIONS AND METHODS FOR PRODUCING 1,8-DIHYDROXYNAPHTHALENE AND CYCLIC HYDROCARBONS FROM 1,8-DIHYDROXYNAPHTHALENE | December 2021 | April 2025 | Abandon | 39 | 0 | 1 | No | No |
| 17551221 | METHOD FOR EXTRACTING FUNCTIONAL INGREDIENTS OF MULBERRY LEAVES USING ENZYMES | December 2021 | February 2025 | Abandon | 38 | 0 | 1 | No | No |
| 17618668 | METHOD FOR THE PRODUCTION OF IODINATED PROTEINS WITH A DETERMINATED IODINE CONTENT | December 2021 | September 2024 | Allow | 33 | 0 | 1 | Yes | No |
| 17617527 | ENGINEERED ACETATE KINASE VARIANT ENZYMES | December 2021 | December 2024 | Allow | 36 | 1 | 1 | No | No |
| 17615160 | Method of Recovering a Protein from Fermentation Broth Using a Divalent Cation | November 2021 | August 2024 | Allow | 33 | 1 | 0 | Yes | No |
| 17615342 | THERMOSTABLE GLUCOSE OXIDASE | November 2021 | September 2024 | Allow | 34 | 1 | 1 | No | No |
| 17614106 | METHOD FOR THE PRODUCTION OF BIOGAS | November 2021 | March 2024 | Allow | 27 | 1 | 0 | Yes | No |
| 17612926 | BACTERIOPHAGES FOR THE TREATMENT OF TUBERCULOSIS | November 2021 | November 2025 | Allow | 48 | 1 | 1 | Yes | No |
| 17525715 | Biological and Chemical Process Utilizing Chemoautotrophic Microorganisms for the Chemosynthetic Fixation of Carbon Dioxide and/or Other Inorganic Carbon Sources into Organic Compounds and the Generation of Additional Useful Products | November 2021 | March 2025 | Abandon | 40 | 3 | 0 | No | No |
| 17611109 | NANORG MICROBIAL FACTORIES: LIGHT-DRIVEN RENEWABLE BIOCHEMICAL SYNTHESIS USING QUANTUM DOT-BACTERIA NANO-BIOHYBRIDS | November 2021 | April 2025 | Abandon | 41 | 0 | 1 | No | No |
| 17595093 | PURIFIED FISH PROTEASES WITH HIGH SPECIFIC ACTIVITIES AND ITS PROCESS OF PRODUCTION | November 2021 | February 2025 | Allow | 39 | 1 | 1 | Yes | No |
| 17608018 | BACTERIA IN 3D POROUS MEDIA | November 2021 | October 2025 | Abandon | 47 | 3 | 1 | No | No |
| 17607248 | ENUMERATION OF GENETICALLY ENGINEERED MICROORGANISMS BY LIVE CELL COUNTING TECHNIQUES | October 2021 | March 2026 | Allow | 52 | 2 | 1 | Yes | No |
| 17508361 | ORAL REHYDRATION COMPOSITION WITH OLIGOSACCHARIDES | October 2021 | February 2024 | Abandon | 28 | 2 | 0 | No | No |
| 17605993 | IN VIVO IMMOBILIZATION OF PROTEINS | October 2021 | April 2025 | Allow | 42 | 2 | 1 | Yes | No |
| 17504858 | CONTINUOUS FLOW METHOD FOR PREPARING (R)-3-HYDROXY-5-HEXENOATE | October 2021 | September 2023 | Allow | 23 | 0 | 1 | Yes | No |
| 17502445 | USE OF MICROBIAL COMMUNITIES FOR HUMAN AND ANIMAL HEALTH | October 2021 | September 2022 | Allow | 11 | 2 | 0 | Yes | No |
| 17603836 | NOVEL ß-AMYLASE AND METHOD FOR UTILIZATION AND PRODUCTION THEREOF | October 2021 | August 2025 | Allow | 46 | 1 | 1 | No | No |
| 17601045 | MUT- METHYLOTROPHIC YEAST | October 2021 | December 2024 | Allow | 39 | 1 | 0 | No | No |
| 17600767 | Process For Producing A Fermentation Product | October 2021 | October 2024 | Abandon | 37 | 1 | 0 | No | No |
| 17442732 | ONCOLYTIC VIRUS AND FOCUSED ULTRASOUND FOR NON-INVASIVE CNS FOCAL GENE DELIVERY | September 2021 | March 2026 | Allow | 53 | 2 | 1 | Yes | No |
| 17436512 | LANTIBIOTICS AND LANTIBIOTIC-PRODUCING BACTERIA | September 2021 | January 2025 | Abandon | 41 | 0 | 1 | No | No |
| 17435530 | LIPID BIOSYNTHESIS AND ABIOTIC STRESS RESILIENCE IN PHOTOSYNTHETIC ORGANISMS | September 2021 | March 2025 | Abandon | 42 | 2 | 1 | No | No |
| 17435588 | ENGINEERED LACTOCOCCUS | September 2021 | September 2025 | Abandon | 48 | 3 | 1 | No | No |
| 17458929 | ASPARAGINE FEED STRATEGIES TO IMPROVE CELL CULTURE PERFORMANCE AND MITIGATE ASPARAGINE SEQUENCE VARIANTS | August 2021 | August 2024 | Allow | 35 | 2 | 1 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SINGH, SATYENDRA K.
With a 31.2% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 28.8% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner SINGH, SATYENDRA K works in Art Unit 1657 and has examined 741 patent applications in our dataset. With an allowance rate of 59.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 37 months.
Examiner SINGH, SATYENDRA K's allowance rate of 59.0% places them in the 19% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by SINGH, SATYENDRA K receive 2.11 office actions before reaching final disposition. This places the examiner in the 56% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by SINGH, SATYENDRA K is 37 months. This places the examiner in the 31% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +73.9% benefit to allowance rate for applications examined by SINGH, SATYENDRA K. This interview benefit is in the 99% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 22.7% of applications are subsequently allowed. This success rate is in the 29% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 22.0% of cases where such amendments are filed. This entry rate is in the 28% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 61.5% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 51% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 65.2% of appeals filed. This is in the 45% percentile among all examiners. Of these withdrawals, 66.7% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 52.3% are granted (fully or in part). This grant rate is in the 52% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 9.3% of allowed cases (in the 93% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.